| Dr Elvira Callahan, DPM | |
|
10230 67th Ave, Suite 1s, Forest Hills, NY 11375-2455 | |
| (718) 275-7590 | |
| (718) 275-2582 |
| Full Name | Dr Elvira Callahan |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 27 Years |
| Location | 10230 67th Ave, Forest Hills, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588647879 | NPI | - | NPPES |
| 02043194 | Medicaid | NY | |
| 4895450001 | Other | NY | MEDICARE DME |
| Facility Name | Location | Facility Type |
|---|---|---|
| New York-presbyterian/queens | Flushing, NY | Hospital |
| Provider Name | Tender Foot Care Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821272782 PECOS PAC ID: 8628049194 Enrollment ID: O20050114000620 |
News Archive
Tumor cells divide fast. They thus require a high supply of components for their DNA, like purines. The biosynthesis of purines could now be a new point of attack for chemotherapy. However, without a natural model, the search for an inhibitor for a cellular process is like the proverbial search for a needle in a haystack. An American research team has developed a clever way to quickly conjure the desired "needle" out of the hay, presenting several candidates to act as starting points for the design of a purine synthesis inhibitor.
Though he has no official government position, Tom Daschle, a former Senate leader and one-time nominee for health secretary, is still attending key health-reform meetings, the Associated Press reports.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that interim data from its Phase 4 retreatment study (AUX-CC-862) evaluating XIAFLEX (collagenase clostridium histolyticum or CCH) in adult patients with Dupuytren's contracture and a recurrent contracture with a palpable cord will be presented for the first time at the American Association for Hand Surgery 2014 Annual Meeting being held January 8-11, 2014 in Kauai, Hawaii.
The U.S. Food and Drug Administration (FDA) released data today on a dedicated website from six studies reflecting a two-month period in response to a requirement under the "FDA Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data" to make transparent the percentage of female and minority participation in clinical trials for medications intended for all populations.
Women with type 2 diabetes and cardiovascular disease (CVD), or at high risk of developing CVD, are less likely to reach recommended treatment targets than men, according to an international study involving almost 10,000 patients with type 2 diabetes, being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year (27 Sept-1 Oct). Nevertheless, women were less likely to experience adverse CVD outcomes apart from a stroke.
› Verified 9 days ago
| Provider Name | New York Queens Medicine And Surgery, P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1003114851 PECOS PAC ID: 4082883673 Enrollment ID: O20110817000163 |
News Archive
Tumor cells divide fast. They thus require a high supply of components for their DNA, like purines. The biosynthesis of purines could now be a new point of attack for chemotherapy. However, without a natural model, the search for an inhibitor for a cellular process is like the proverbial search for a needle in a haystack. An American research team has developed a clever way to quickly conjure the desired "needle" out of the hay, presenting several candidates to act as starting points for the design of a purine synthesis inhibitor.
Though he has no official government position, Tom Daschle, a former Senate leader and one-time nominee for health secretary, is still attending key health-reform meetings, the Associated Press reports.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that interim data from its Phase 4 retreatment study (AUX-CC-862) evaluating XIAFLEX (collagenase clostridium histolyticum or CCH) in adult patients with Dupuytren's contracture and a recurrent contracture with a palpable cord will be presented for the first time at the American Association for Hand Surgery 2014 Annual Meeting being held January 8-11, 2014 in Kauai, Hawaii.
The U.S. Food and Drug Administration (FDA) released data today on a dedicated website from six studies reflecting a two-month period in response to a requirement under the "FDA Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data" to make transparent the percentage of female and minority participation in clinical trials for medications intended for all populations.
Women with type 2 diabetes and cardiovascular disease (CVD), or at high risk of developing CVD, are less likely to reach recommended treatment targets than men, according to an international study involving almost 10,000 patients with type 2 diabetes, being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year (27 Sept-1 Oct). Nevertheless, women were less likely to experience adverse CVD outcomes apart from a stroke.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elvira Callahan, DPM 10230 67th Ave, Suite 1s, Forest Hills, NY 11375-2455 Ph: (718) 275-7590 | Dr Elvira Callahan, DPM 10230 67th Ave, Suite 1s, Forest Hills, NY 11375-2455 Ph: (718) 275-7590 |
News Archive
Tumor cells divide fast. They thus require a high supply of components for their DNA, like purines. The biosynthesis of purines could now be a new point of attack for chemotherapy. However, without a natural model, the search for an inhibitor for a cellular process is like the proverbial search for a needle in a haystack. An American research team has developed a clever way to quickly conjure the desired "needle" out of the hay, presenting several candidates to act as starting points for the design of a purine synthesis inhibitor.
Though he has no official government position, Tom Daschle, a former Senate leader and one-time nominee for health secretary, is still attending key health-reform meetings, the Associated Press reports.
Auxilium Pharmaceuticals, Inc., a fully integrated specialty biopharmaceutical company, today announced that interim data from its Phase 4 retreatment study (AUX-CC-862) evaluating XIAFLEX (collagenase clostridium histolyticum or CCH) in adult patients with Dupuytren's contracture and a recurrent contracture with a palpable cord will be presented for the first time at the American Association for Hand Surgery 2014 Annual Meeting being held January 8-11, 2014 in Kauai, Hawaii.
The U.S. Food and Drug Administration (FDA) released data today on a dedicated website from six studies reflecting a two-month period in response to a requirement under the "FDA Action Plan to Enhance the Collection and Availability of Demographic Subgroup Data" to make transparent the percentage of female and minority participation in clinical trials for medications intended for all populations.
Women with type 2 diabetes and cardiovascular disease (CVD), or at high risk of developing CVD, are less likely to reach recommended treatment targets than men, according to an international study involving almost 10,000 patients with type 2 diabetes, being presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD), held online this year (27 Sept-1 Oct). Nevertheless, women were less likely to experience adverse CVD outcomes apart from a stroke.
› Verified 9 days ago
Stephen B. Chernick, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 11247 Queens Blvd, Suite 104/105, Forest Hills, NY 11375 Phone: 718-793-3223 Fax: 718-793-0838 | |
Dr. Christian Jonathan Wower, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 9610 Metropolitan Ave, Forest Hills, NY 11375 Phone: 718-459-0400 Fax: 718-670-6479 | |
Scott Lurie & David Rossman Ptrs Forest Hills Podiatric Medical Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 71 11 110th Street, Forest Hills, NY 11375 Phone: 718-520-8811 Fax: 718-520-6646 | |
Dr. Marina Greyman, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 6420 108th St, Forest Hills, NY 11375 Phone: 718-520-6500 Fax: 718-520-6595 | |
Dr. Lekeisha Yolanda George, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7111 110th St, Forest Hills, NY 11375 Phone: 718-520-8811 Fax: 718-520-6646 | |
Dr. Katy Mc Allister, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6902 Austin St, 2nd Floor, Forest Hills, NY 11375 Phone: 718-793-6800 Fax: 718-947-1018 | |
Dr. Daniel Grapel, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 10721 Queens Blvd, Forest Hills, NY 11375 Phone: 718-793-5511 Fax: 718-793-5512 |